Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Recently, clinical studies have shown activity of Immune Checkpoint Inhibitors (ICI) in patients with advanced CSCC.
ICI is currently the most effective and tolerable systemic therapy in the treatment of non-immunosuppressed advanced CSCC and can lead to cure in a subset of patients
see also:
Abexinostat + Pembrolizumab & Cutaneous squamous cell carcinoma (CSCC)
Anti-PD-1 Antibodies / PD-1 Inhibitors & Cutaneous Squamous Cell Carcinoma (CSCC)
[Cancer immunotherapy / Immuno-Oncology & Cutaneous…